However, Picklo et al. [24] reported AKR7A2 expression to be elevated in cerebral cortexes of Alzheimer's disease patients, a disease associated with elevated aldehyde products. This evidence concerns the gene AKR7A2 and early-onset autosomal dominant Alzheimer disease.